Successful treatment of refractory cold agglutinin syndrome using fixed duration daratumumab, bortezomib and dexamethasone with a sutimlimab bridge
Year: 2025
Type: article
Abstract: Not available.
Source: Haematologica
Authors: Brad Rybinski, Miranda James, Nancy Hardy, Rima Koka, Aaron P. Rapoport
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W4410586624
